MoneyWorks4Me

Novartis India informs about statement of investor complaints

14 Jul 2017 Evaluate

Novartis India has informed about Statement of Investor Complaints/Grievances pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for the Quarter ended June 30, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers